Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-970-0 | CAS number: 256-96-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- May 05 to 15, 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well documented and reported study, conducted according to internationally accepted technical guideline and in compliance with GLP in recognized industrial research organization.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- of 1987
- Deviations:
- yes
- Remarks:
- The volume of 0.1 g test material was too high for application. Therefore, only 0.06 to 0.072 g of test material was administered into the conjunctival sac of one eye per rabbit.
- GLP compliance:
- yes
Test material
- Reference substance name:
- 5H-dibenz[b,f]azepine
- EC Number:
- 205-970-0
- EC Name:
- 5H-dibenz[b,f]azepine
- Cas Number:
- 256-96-2
- Molecular formula:
- C14H11N
- IUPAC Name:
- 5H-dibenzo[b,f]azepine
- Details on test material:
- - Name of test material (as cited in study report): PBS 7049, iminostilben dry intermediate
- Supplier: Pharma Chemical Production
- Description: orange crystalline powder
- Expiration date of the lot/batch: 03/96
- Storage conditions: room temperature
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- other: Russian rabbit, Chbb:HM (SPF)
- Details on test animals or tissues and environmental conditions:
- - Animal supplier: Dr. K. Thomae, GmbH, Biberach (FRG)
- Initial Age (at dosing): 47 - 53 weeks.
- Number and sex of animals: 3 male rabbits.
- Weight on day of treatment (at dosing): Minimum 2.593 kg, maximum 2.805 kg.
- Housing: Individual housing in stainless steel cages.
- Diet (ad libitum): Commercially available pelleted standard diet (NAFAG No. 814, analysed by the
manufacturer, NAFAG, 9202 Gossau, Switzerland).
- Water (ad libitum): Tap water. (Periodically analysed)
- Acclimation period: At least 5 days under laboratory conditions.
ENVIRONMENTAL CONDITIONS
Air conditioned room:
- Temperature (°C): 20 ± 3°C
- Relative Humidity (%): 30 to 70%
- Photoperiod: 12 hrs artificial light/day
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- The volume of 0.1 g test material was too high for administration. Therefore, a single dose of only 0.06 to 0.072 g of unchanged test material was administered into the conjunctival sac of one eye per rabbit. The contralateral eye remained untreated to serve as a control.
- Duration of treatment / exposure:
- There was no mentioning in the report that eyes were rinsed after treatment. Consequently the treatment/exposure period was equivalent to the entire observation period following administration, which was 7 days, or lasted until removal of the test material by physiological mechanisms, whichever happened sooner.
- Observation period (in vivo):
- 7 days
- Number of animals or in vitro replicates:
- 3 male rabbits
- Details on study design:
- There was no mentioning in the report that eyes were rinsed after administration of the test material.
Eyes were evaluated according to the OECD scoring system at: Pretest (prior to treatment), 1, 24, 48 and 72 hours and 7 days after administration. Grades attained at 24, 48 and 72 hours after administration were included in the mean gradings of ocular lesions used for eye irritation/corrosion classification.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- over 3 animals and 3 time points
- Time point:
- other: 24, 48, 72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: Corneal ulceration or opacity was not evident
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- over 3 animals and 3 time points
- Time point:
- other: 24, 48, 72 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- other: Iridal changes were not evident
- Irritation parameter:
- conjunctivae score
- Remarks:
- (redness)
- Basis:
- mean
- Remarks:
- over 3 animals and 3 time points
- Time point:
- other: 24, 48, 72 h
- Score:
- 0.56
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- over 3 animals and 3 time points
- Time point:
- other: 24, 48, 72 h
- Score:
- 0.22
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 h
- Irritant / corrosive response data:
- Untreated control eyes were always free from ocular lesions in all animals. In addition at pre-dose, eyes foreseen for treatment were free from ocular lesions in all animals. In the eye treated with test material, one of the three animals did not show any ocular lesion throughout the study, the other two animals showed conjunctival redness grade 1 and chemosis grade 1. Conjunctival redness (grade 1) was seen at 1, 24, 48 and/or 72 hours after administration having fully reversed by 72 hours or 7 days in the two affected animals. Chemosis (grade 1) was seen at 1 and 24 hours after administration having fully reversed by 48 hours in both affected animals. Corneal and iridic lesions were not evident throughout the study.
- Other effects:
- There was no mortality. Systemic clinical signs or relevant changes in body weight were not evident.
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- PBS 7049 had only minimal effects on the eye not necessitating any labelling regarding eye irritation according to EU classification rules [DIRECTIVE 67/548/EEC and REGULATION (EC) 1272/2008].
- Executive summary:
PBS 7049 was tested for eye irritation according to OECD Guideline 405 and in compliance with GLP. Reliability grade 1 was assigned to the study.
Each of three Russian rabbits [Chbb:HM (SPF)] was treated by administration of a single dose of 60 to 72 mg test material to the conjunctival sac of one eye. The test material volume attained from 100 mg, usually dosed in such eye irritation studies, was too high for administration. The other eye served as a control in each animal. Eyes were evaluated for ocular lesions prior to dosing and at 1, 24, 48 and 72 hours and 7 days after administration. In addition, general clinical signs, mortality and bodyweights were recorded on a number of occasions.
There was no mortality. Systemic clinical signs or relevant changes in body weight were not evident. The only ocular lesions seen in the present study were conjunctival redness (grade 1) and chemosis (grade 1) in the treated eye in two of the three animals. The conjunctival redness finding was seen at 1, 24, 48 and/or 72 hours after administration having fully reversed by 72 hours or 7 days and the chemosis was seen at 1 and 24 hours after administration having fully reversed by 48 hours in the two affected animals. Corneal and iridic lesions were not evident throughout the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.